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Stem cell transplantation promises new hope for the treatment of stroke although signiﬁcant questions remain about how the
grafted cells elicit their effects. One hypothesis is that transplanted stem cells enhance endogenous repair mechanisms activated
after cerebral ischaemia. Recognizing that bilateral reorganization of surviving circuits is associated with recovery after stroke,
we investigated the ability of transplanted human neural progenitor cells to enhance this structural plasticity. Our results show
the ﬁrst evidence that human neural progenitor cell treatment can signiﬁcantly increase dendritic plasticity in both the ipsi- and
contralesional cortex and this coincides with stem cell-induced functional recovery. Moreover, stem cell-grafted rats demon-
strated increased corticocortical, corticostriatal, corticothalamic and corticospinal axonal rewiring from the contralesional side;
with the transcallosal and corticospinal axonal sprouting correlating with functional recovery. Furthermore, we demonstrate that
axonal transport, which is critical for both proper axonal function and axonal sprouting, is inhibited by stroke and that this is
rescued by the stem cell treatment, thus identifying another novel potential mechanism of action of transplanted cells. Finally,
we established in vitro co-culture assays in which these stem cells mimicked the effects observed in vivo. Through immuno-
depletion studies, we identiﬁed vascular endothelial growth factor, thrombospondins 1 and 2, and slit as mediators partially
responsible for stem cell-induced effects on dendritic sprouting, axonal plasticity and axonal transport in vitro. Thus, we
postulate that human neural progenitor cells aid recovery after stroke through secretion of factors that enhance brain repair
and plasticity.
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Introduction
Stem cell therapy has emerged as a promising new experimental
treatment strategy for stroke and other diseases of the CNS.
Transplanted neural- or mesenchymal-derived progenitor cells are
known to survive and migrate in the rodent brain after ischaemic
damage and to improve functional recovery (Chen et al., 2001,
2003; Kelly et al., 2004; Guzman et al., 2008; Hicks et al., 2009;
Darsalia et al., 2010). Initial clinical trials demonstrated the feasi-
bility of cell therapy in patients with stable and persistent stroke
deﬁcits (Bang et al., 2005; Kondziolka et al., 2005; Savitz et al.,
2005), and currently six new clinical trials are in progress (Bliss
et al., 2010). However, despite many preclinical studies showing
that cell transplantation can improve recovery from stroke, the
mechanisms mediating recovery are unknown.
One hypothesis is that stem cells, through secretion of factors,
act to enhance endogenous repair mechanisms normally activated
in the brain after stroke such as vascular repair, immunomodula-
tion, endogenous neurogenesis and brain plasticity (Arvidsson
et al., 2002; Taguchi et al., 2004; Liu et al., 2008; Ohtaki
et al., 2008; Bliss et al., 2010; Li et al., 2010; Horie et al.,
2011). Brain plasticity is thought to play a major role in the spon-
taneous recovery observed in patients and animals after stroke
with the dramatic reorganization and rewiring of surviving circuits
enabling the healthy brain to take over the function of the
damaged area (Dancause, 2006; Murphy and Corbett, 2009;
Benowitz and Carmichael, 2010). Functional imaging and stimula-
tion studies in patients have shown a remapping of the brain after
stroke which, at least in the ﬁrst few weeks, indicates recruitment
of both ipsi- and contralesional brain areas. Animal studies yielded
similar results (Dijkhuizen et al., 2003; Takatsuru et al., 2009) and
suggest this gross remapping is caused by local and long distant
changes in axonal sprouting and dendritic arborization (Jones and
Schallert, 1992; Gonzalez et al., 2003), which we deﬁne here as
structural plasticity.
Recovery from neurological deﬁcits will also depend on restor-
ation of axonal function. Many circuits remain intact after stroke,
but are potentially impaired due to disruption of axonal transport
(Kataoka et al., 1989; Valeriani et al., 2000; Wakita et al., 2002);
this is particularly relevant to white matter tract injury. Axonal
transport is critical for neuron function; transport of molecules
and organelles between the cell body and the axon terminal is
essential for neurotransmission. Furthermore, axonal transport is
critical for the relay of molecules that signal axonal sprouting or
degeneration, and synapse formation or retraction (Coleman,
2005; Salehi et al., 2009). Therefore, restoration of impaired
axonal transport after stroke is likely to be key for both the
proper functioning of existing axons and for plasticity changes
such as axonal sprouting and synaptogenesis.
The factors involved in signalling axonal and dendritic changes
after stroke are not really understood but many molecules are
known to promote neurite sprouting either in culture or in vivo
(Carmichael et al., 2005). Such molecules include neurotrophic
factors like vascular endothelial growth factor (VEGF) and basic
ﬁbroblast growth factor (Himmelseher et al., 1997; Rosenstein
et al., 2003), extracellular matrix molecules like the thrombospon-
dins and secreted protein acidic and rich in cysteine (SPARC)
(Osterhout et al., 1992; Au et al., 2007; Liauw et al., 2008)
and factors important for neurite growth and guidance during
development like Slit (Lin and Isacson, 2006). Neural progenitor
cells express many such factors known to inﬂuence neurite plasti-
city (Wright et al., 2003) and thus have the potential to enhance
structural plasticity after stroke. Therefore, in the present study,
we determined the effects of transplanted human neural progeni-
tor cells (NPCs) on structural plasticity and axonal transport in the
ischaemic rat brain and correlated this with human NPC-induced
recovery. Furthermore, we investigated the potential of several
human NPC-secreted factors to induce such plasticity and trans-
port changes in vitro.
Materials and methods
Human neural progenitor cell culture
Human NPCs, initially isolated from foetal cortical brain tissue at 13.5
weeks gestation (M031 clone), were cultured as neurospheres in
Stemline
TM Neural Stem Cell Expansion Medium (Sigma) supple-
mented with 20ng/ml epidermal growth factor (Sigma) and
10ng/ml leukaemia inhibitory factor (Chemicon) as previously
described (Svendsen et al., 1998). For transplantation and in vitro
experiments, human NPCs (passages 16–25) were dissociated to a
single cell suspension by incubation at 37C with Accutase (10min;
Sigma), trypsin inhibitor (5min; Sigma) and DNase (10min; Sigma),
followed by gentle trituration.
Stroke surgery and cell transplantation
Animal procedures were approved by Stanford University’s
Administrative Panel on Laboratory Animal Care. T cell-deﬁcient
adult male Nude rats (Cr:NIH-RNU 230  30g; NCI-Frederick
Cancer Research) were subjected to permanent distal middle cerebral
artery occlusion with 0.5h bilateral common carotid artery occlusion as
described (Kelly et al., 2004) under isoﬂurane anaesthesia. Ampicillin
(1mg/ml) was administered orally 3 days before stroke surgery to
7 days post-transplantation surgery. At 7 days post-distal middle cere-
bral artery occlusion, three 1.0ml deposits of human NPCs (1  10
5
cells/ml), or vehicle (0.9% saline), were injected into the ipsilesional
cortex as described (Kelly et al., 2004): (i) anterior–posterior
(A–P), + 1.0; medial–lateral (M–L), 1.2; dorsal–ventral (D–V), 2.7;
(ii) A–P, 0.26; M–L, 1.2; D–V, 2.6; and (iii) A–P, 1.8; M–L,
1.0; D–V, 1.8. Rats were housed in groups of two or three in cages
containing a plastic toy (polyvinyl chloride tubing), with free access to
food and water. A total of three rats died in the ﬁrst 24h after induction
of stroke. Otherwise, no animals were excluded from the study.
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Behaviour was tested preoperatively for baseline performance and re-
peated weekly for 6 weeks post-stroke by an investigator blinded to
treatment (n = 12 per group, except cylinder test n = 6). Animals were
randomized at 1 week post-stroke, prior to treatment, based on their
behaviour scores in the vibrissae-elicited forelimb placing test. No ani-
mals were excluded from the study. (i) Vibrissae-elicited forelimb pla-
cing test: 10 trials of the vibrissae-evoked forelimb placing test were
carried out on each side as described previously (Schallert et al., 2000);
(ii) cylinder test (Schallert et al., 2000): rats were placed in a plastic
cylinder and the number of times they reared and touched the cylinder
in a weight-bearing fashion with the left, right, or both forelimbs was
counted for 20 hits. The right:left ratio was calculated; (iii) elevated
body swing test (Borlongan and Sanberg, 1995): rats were lifted by
the proximal tail 3cm above the table, the direction of swing in order
to reach upward was recorded for 10 trials; (iv) postural reﬂex test
(Bederson et al., 1986): animals were suspended by the proximal tail,
1m above the ground and slowly lowered. Symmetric touch-down
with both forelimbs scored 0 points and testing ended. Animals with
abnormal postures (rotating body, ﬂexing of limbs) were placed on the
table and gently pushed side-to-side. Rats resistant to pushing scored
1 point, animals unable to resist scored 2 points.
Tissue processing and immunostaining
Rats were perfused as previously described (Kelly et al., 2004), brains
and cervical spinal cords removed and 30mmo r2 0mm coronal sections
cut, respectively. Immunostaining was performed conventionally (Kelly
et al., 2004) using primary and secondary antibodies as described in
the Supplementary material, followed by confocal microscopy analysis.
To assess the human NPC differentiation proﬁle, Z-stacks were
acquired and 100 or more human nuclear antigen-positive cells in
the peri-infarct area were scored for each marker (Nestin, neuronal
class III b-Tubulin, glial ﬁbrillary acidic protein, NG2, Olig2). Pixel
intensity of growth-associated protein-43 (GAP-43) staining was
analysed using ImageJ in six brain slices encompassing the entire
lesion. All histological analyses were carried out in a blinded fashion.
Analysis of axonal transport in vivo
Immunohistochemistry for axonal amyloid precursor protein was per-
formed as previously described (Stone et al., 2000; Supplementary
material) using rabbit anti-amyloid precursor protein (C-terminus;
1:2000; Invitrogen) with the mouse anti-neural ﬁlament (anti-
SMI312) antibody (1:1000; Sternberger Monoclonals). Brains were
analysed (blinded) at 3 weeks (n = 6) and 12 weeks (n = 12) after
transplantation. Confocal images were acquired from six sections per
animal (500mm apart) in two regions of interest per section, namely
the ipsi- and contralesional genu of the corpus callosum. The total
number of SMI312-positive ﬁbres per region of interest and the
ratio of amyloid precursor protein/SMI312-co-localizing axons were
analysed using the ‘Puncta Analyzer’ plugin for NIH ImageJ software,
as described previously (Liauw et al., 2008; Supplementary material),
and averaged over the six sections.
Analysis of infarct size and corpus
callosum thickness
Infarct size was determined by an investigator blinded to treatment, on
six cresyl violet stained sections taken at 540mm intervals between the
levels +1.2 to –1.6mm from bregma and expressed as percentage of
the contralateral, non-ischaemic hemisphere as described previously
(Kelly et al., 2004). Corpus callosum thickness was measured (blinded)
at the midline on bregma level slices (n = 12 per group, except naı ¨ve
animals, n = 5).
Dendritic analysis
Rats were anaesthetized with isoﬂurane (n = 4–5 per group at 2 weeks
post-transplantation, n = 5 per group at 4 weeks post-transplantation),
the brains were removed and stained using a Rapid GolgiStain
TM Kit
(FD NeuroTechnologies) and 150mm coronal sections cut. Layer V
pyramidal neurons were analysed (blinded) in the region between the
lesion and the human NPC graft and the equivalent location in the
contralesional cortex, i.e. between bregma and bregma 1.2mm, be-
tween the dorsal peak of the corpus callosum and up to 4mm from
the midline. Five neurons per hemisphere per animal were analysed.
To be included, neurons had to be well impregnated, in full view with
no overlapping blood vessels or astrocytes, appear intact and in
the plane of section. The length of each dendritic branch was deter-
mined using the measuring tool on the StereoInvestigator software
(MicroBrightField) and following the dendrite through the Z-axis; the
number of branches was tabulated at the same time. Branch order was
analysed as shown in Fig. 2 (Coleman and Riesen, 1968).
Axonal tracing studies
At 2 (n = 6) or 4 weeks (n = 12) post-transplantation, rats were
injected with 0.2ml of the anterograde axonal tracer biotinylated dex-
tran amine (BDA, molecular weight 10 000, 0.1mg/ml; Molecular Probes)
at0.1ml/minintothecontralesionallayerVcortexat:(i)A–P, 1.0;M–L,
1.3; D–V, 1.8; (ii) A–P, 1.0; M–L, 1.8; D–V, 1.8; (iii) A–P,
0.5; M–L, 1.3; D–V, 1.8; and (iv) A–P, 0.5; M–L, 1.8; D–V,
1.8. The needle was left in situ for 5min then slowly removed. After 1
week brains and cervical spinal cord were processed for immunohisto-
chemistry: after 30min permeabilization with digitonin (100mg/ml;
Calbiochem), BDA was detected using streptavidin-conjugated antibody
(Alexa Fluor 546, 1:200; Molecular Probes). Biotinylated dextran
amine-positive ﬁbres were determined by a stereological approach
(Supplementary material). In brief, confocal images were acquired
from deﬁned regions of interest in six deﬁned brain slices encom-
passing the entire ischaemic area, and from the dorsal funiculus of
the spinal cord at level C5. BDA-positive ﬁbre densities were
calculated using ImageJ software by determining the number of
pixels above a set intensity threshold. The values were normalized
to the number of BDA-positive cell bodies. Image acquisition and
analysis were done in a blinded fashion. Quantiﬁcation of BDA-
positive ﬁbres was validated by a second, manual counting process
as previously described (Kartje et al., 1999; Chen et al., 2002)
(Supplementary material).
RNA extraction and quantitative
polymerase chain reaction analysis
Brains were removed from human NPC- or vehicle-transplanted is-
chaemic rats 1 week post-transplantation (n = 4 per group). RNA
was extracted from the transplantation sites and human gene expres-
sion determined using human-speciﬁc Taqman Gene Expression Assays
(Applied Biosystems). Refer to the Supplementary material for details.
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assays
Primary cortical cultures from Sprague-Dawley rat E14 embryos
(Charles River Laboratories) were prepared as described (Andres
et al., 2005; Supplementary material). After 3 days in vitro human
NPCs (180000 cells) or vehicle were added to the primary cultures in
cell culture inserts (Falcon 353095). For immunodepletion studies, neu-
tralizing antibodies were added to the medium in the wells and inserts
at 5mg/ml from Days 3–7 in vitro (see Supplementary material). At
Day 7 in vitro, the cortical cultures were ﬁxed and axons labelled with
anti-SMI312 (1:1000) and dendrites with anti-microtubule-associated
protein 2 (MAP2, 1:400; BD Pharmingen), followed by secondary
antibodies (Alexa Fluor 488 or 546 conjugated goat anti-mouse,
1:250; Molecular Probes). Fluorescent images of randomly selected
ﬁelds were acquired and neurite outgrowth and MAP2-positive cell
numbers analysed using automatic neurite tracing software (HCA
Vision V1.6.5, CSIRO). Minor processes measuring 56mm were
excluded from the axonal analysis. For neurite outgrowth assays,
42–458 individual cells from 3–6 independent experiments were ana-
lysed per group. For cell number analysis, 6–12 cultures were analysed
per group from 3–6 independent experiments.
Microﬂuidics axonal transport assay
E14 rat embryonic primary cortical cultures were grown in the ‘cell
body’ chamber of a microﬂuidics device (Taylor et al., 2005;
Supplementary material). At Day 3 in vitro, 120000 human NPCs
or vehicle were added to the distal chamber. At Day 5 in vitro,
when axons of the primary cultures had extended through the micro-
grooves, Alexa Fluor 488-conjugated dextran (0.1mg/ml; molecular
weight 10000, anionic, Nr. D-22910, Invitrogen) was added to the
cell body chamber, and anterograde transport of dextran-labelled ves-
icles was analysed as reported (Kunzi et al., 2002). In brief, 2h after
dextran labelling, time-lapse ﬂuorescent images were acquired every
12.5s. Transport velocities of individual anterogradely transported ves-
icles were calculated if they were identiﬁable for at least six frames in a
series. Vesicles with velocities 50.1mm/s were discarded to exclude
movements caused by Brownian motion (Kunzi et al., 2002).
Immunodepletion studies were carried out as described above with
antibodies added to both the cell body and distal compartments. A
total of 140–840 vesicles were analysed per group, from four inde-
pendent experiments.
Statistical evaluation
Statistical analysis utilized GraphPad Instat (GraphPad Software) and
JMP 8.0.1 (SAS Institute). In vivo dendritic data analysis consisted of
repeated measures ANOVA using PROC GLM, a procedure in SAS, to
compare treatment effects after adjusting for subject effects. ANOVA
assumptions were examined with residual plots. For all other data,
experimental groups were compared by ANOVA, followed by
non-parametric post hoc Mann–Whitney test, or Student’s t-test.
Biotinylated dextran amine or amyloid precursor protein values (from
the genu of the contralateral corpus callosum) were tested for correl-
ation with functional recovery (deﬁned as change in behaviour from
Week 1 to Week 6 post-stroke) using the Spearman test; both the
Spearman coefﬁcient and signiﬁcance values are given. Differences
were considered statistically signiﬁcant at P50.05. Values are pre-
sented as mean  SEM.
Results
Transplanted human neural precursor
cells survive in the ischaemic host brain,
reduce white matter atrophy and
enhance functional recovery
Human NPCs transplanted into the rat cortex 7 days post-stroke
exhibited robust survival and migration towards the lesion at
5 weeks post-transplantation (Fig. 1A). The majority of the
human NPCs stained with nestin (78.2  6.0%) implying
that most cells remained in an immature state at this time, con-
sistent with previous work (Kelly et al., 2004; Hicks et al., 2009).
A small proportion of cells expressed the astrocyte marker glial
ﬁbrillary acidic protein (17.2  7.9) or the immature neuronal
marker b-tubulin (neuronal class III b-Tubulin; 4.6  2.2%)
(Fig. 1B and C). No co-localization was observed with the
oligodendroglial markers NG2 and Olig2. Lesion size was not
signiﬁcantly different between human NPC- and vehicle-treated
rats at 5 weeks post-transplant (21.2  3.7% and 15.3  1.9%,
respectively; Supplementary Fig. 1A), but atrophy of the corpus
callosum was signiﬁcantly reduced in human NPC-treated
animals at this time point [corpus callosum thickness (mm):
222  13.8 (vehicle) versus 277  11.3 (human NPC); P50.05;
Supplementary Fig. 1B]. Human NPC-grafted rats showed sig-
niﬁcantly enhanced functional recovery in three out of four
behaviour tests compared with vehicle controls (MANOVA
P50.05) which started between 3 and 4 weeks post-
transplantation.
Human neural precursor cell
transplantation promotes
dendritic plasticity
Golgi-stained dendrites from layer V cortical pyramidal neurons
(Fig. 2C) were analysed between the lesion and the graft (and
the corresponding region of interest in the contralateral cortex).
Human NPC treatment enhanced dendritic branching and total
dendritic length at 2 weeks post-transplantation in both hemi-
spheres compared with vehicle controls (Fig. 2A and B). Of
note, vehicle injection appeared detrimental to dendritic plasticity
in the injected (ipsilesional) hemisphere compared with non-
treated stroke animals at this time point (Fig. 2A and B). Human
NPC-induced dendritic changes in the contralesional hemi-
sphere abated by 4 weeks post-transplant. In contrast, the effects
in the ipsilesional hemisphere were sustained suggesting that prox-
imity to the human NPCs is important to maintain enhanced den-
dritic plasticity. Changes in dendritic branching were more
signiﬁcant in basilar branches when compared with apical
branches (Fig. 2D–F), and the greatest plasticity was observed in
the middle order branches (branch orders 3–7) rather than in
branches emanating from the soma or at the dendrite extremities
(Fig. 2E and F).
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transplantation promotes axonal
rewiring after stroke
The anterograde axonal tracer biotinylated dextran amine (BDA)
injected into the contralesional cortex was used to visualize axons.
Human NPC-grafted rats, compared with vehicle-treated rats, ap-
peared to increase axonal sprouting from the contralesional cortex
to the ipsilesional hemisphere (Fig. 3A). This was ﬁrst evident at 3
weeks post-transplantation with increased BDA-labelled ﬁbre
density in the corpus callosum and ipsilesional striatum of
human NPC-treated animals (Fig. 3B). This effect was even
more pronounced at 5 weeks post-transplantation with increased
corticocortico, corticostriatal and corticothalamic sprouting as evi-
denced by signiﬁcantly increased BDA-labelled ﬁbre density in the
relevant regions of interest as indicated in Fig. 3B and C. Unlike
human NPC-treated animals, the vehicle-treated group showed no
increase in BDA-positive ﬁbres over time. Human NPC-grafted rats
also showed enhanced corticospinal tract projections at 5 weeks
post-transplantation with signiﬁcantly increased BDA-labelled ﬁbre
density in the contralesional internal capsule and both the contra-
and ipsilesional dorsal funiculus of the cervical spinal cord
(Fig. 3D). Similar results were found when BDA was analysed
by a second counting method (Supplementary material and
Supplementary Fig. 2). To further substantiate human NPC-
induced plasticity, we found that human NPC treatment signiﬁ-
cantly enhanced expression of the axonal growth cone protein
GAP-43 in the corpus callosum and cortex of both hemispheres,
with the largest increase in the ipsilesional cortex (Supplementary
Fig. 1C). BDA labelling in the corpus callosum at 5 weeks
post-transplantation positively correlated with functional recovery
in the whisker-paw (Spearman correlation coefﬁcient  = 0.802;
P = 0.001) and cylinder tests (Spearman correlation coefﬁcient
 = 0.642; P = 0.028) when combining data from both vehicle
and human NPC groups. Recovery in the whisker-paw test
also positively correlated with the BDA signal in the injured
corticospinal tract (Spearman correlation coefﬁcient  = 0.631;
P = 0.032). There was no correlation between lesion size
and BDA signal. These data suggest that human NPC-induced
axonal changes are important for human NPC-enhanced
recovery.
Identiﬁcation of human neural precursor
cell-secreted factors that modulate
dendritic and axonal plasticity
In a non-contact co-culture assay (Supplementary Fig. 3), human
NPCs signiﬁcantly increased (per neuron) dendritic branching
(Fig. 4A and B), total dendritic length (Fig. 4A and C) and axonal
length (Fig. 4A and D) of co-cultured cortical neurons, thus
mimicking in vitro the human NPC-mediated effects on dendritic
and axonal plasticity observed in vivo. To identify potential human
NPC-secreted plasticity mediators, immunodepletion studies were
done for speciﬁc candidate molecules known to be involved in
neuronal plasticity and shown to be expressed in our human
NPCs by microarray analysis (Wright et al., 2003). Neutralization
of thrombospondins 1 and 2 or human VEGF signiﬁcantly reduced
human NPC-induced dendritic branching and length, while neu-
tralization of Slit only affected total dendritic length with no effect
on dendritic branching (Fig. 4B and C). Human NPC-mediated
axonal outgrowth was signiﬁcantly reduced by neutralization of
all the aforementioned factors (Fig. 4D); neutralization of
Figure 1 Differentiation fate of transplanted human NPCs and
effect on behavioural recovery after stroke. (A) Human NPCs
(human nuclear antigen
+ cells; red) exhibit good survival and
migration towards the lesion at 5 weeks post-transplantation.
Representative photomicrograph of human NPCs in the
peri-infarct region. Grey-shaded area indicates the lesion.
(B) Differentiation proﬁle of the human NPCs at 5 weeks
post-transplant. (C) Confocal images of differentiation markers
co-localizing with human nuclear antigen in the peri-infarct area.
(D) Human NPC-grafted animals have signiﬁcantly improved
functional recovery compared with vehicle-injected controls in
three out of four behaviour tests; *P50.05, **P50.01. n =1 2
per group, except cylinder test n = 6. Scale bars: A =5 0mm,
C =1 0mm. GFAP = glial ﬁbrillary acidic protein; HuNu = human
nuclear antigen; TuJ1 = neuronal class III b-Tubulin;
Tx = transplantation.
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treated cortical neurons. Depletion of SPARC had no effect on
either dendritic or axonal morphology (Fig. 4B–D). The effects of
the neutralizing antibodies were speciﬁc as isotype control antibo-
dies had no effect (P40.05). Quantitative polymerase chain re-
action analysis of the stroke brains 1 week post-transplantation
revealed that at least four of these factors (VEGF, thrombospon-
dins 1, 2 and SPARC) were expressed by the transplanted human
NPCs (Table 1 and Supplementary Fig. 4), indicative of a potential
role in vivo.
In addition to effects on neurite outgrowth in vitro, human
NPCs enhanced survival of the primary neurons at Day 7
[245  24 cells/mm
2 (human NPCs) versus 348  27 cells/
mm
2 (+human NPCs); P = 0.02]. Depletion of thrombospondin
1 or human VEGF signiﬁcantly reduced human NPC-induced
neuron survival [218  23 cells/mm
2 (thrombospondin 1);
260  21 cells/mm
2 (human VEGF); P50.05 compared with
human NPCs with no neutralization]. In contrast, depletion of
thrombospondin 2, SPARC or Slit had no effect.
Transplanted human neural precursor
cells reduce impairment of axonal
transport post-ischaemia
Disruption of anterograde axonal transport was quantitatively as-
sessed by measuring amyloid precursor protein accumulation in
axons (labelled with the neuroﬁlament marker SMI 312). There
was signiﬁcant accumulation of amyloid precursor protein in
axons in the corpus callosum after stroke (Fig. 5A and B), consist-
ent with previous reports of stroke impaired axonal transport
(Valeriani et al., 2000; Wakita et al., 2002). Human NPC-grafted
animals had signiﬁcantly fewer amyloid precursor protein-positive
axons at 3 weeks compared with vehicle controls (Fig. 5B), and
this difference was further enhanced by 5 weeks suggesting that
human NPCs enhance recovery of axonal transport. Furthermore,
at 5 weeks human NPC animals had more axons in the corpus
callosum as determined by the number of SMI312 puncta
(Fig. 5C). Together, these data imply that human NPC-treated
animals have more functioning axons (i.e. axons without impaired
Figure 2 Human NPC transplantation enhances dendritic plasticity after stroke. (A and B) Human NPCs enhance dendritic length (A) and
branching (B) at 2 weeks post-transplantation in both the ipsi- and contralesional cortex compared with vehicle-treated animals (n = 4–5
per group). These effects are sustained to 4 weeks post-stroke (n = 5 per group) only in the ipsilesional hemisphere. (C) Representative
image of a golgi-stained layer V neuron. (D) Schematic illustrating how branch order is counted for apical and basilar dendrites. (E and F)
At 4 weeks post-transplantation human NPCs enhance branching in the middle order branches in ipsilesional layer V neurons. This is more
signiﬁcant in basilar branches (E) compared with apical branches (F). *P50.05; **P50.01; ***P50.001;
#P = 0.05.
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precursor protein accumulation in the corpus callosum showed
an overall negative correlation with recovery in the whisker-paw
(Spearman correlation coefﬁcient  = 0.689; P = 0.015) and
cylinder test (Spearman correlation coefﬁcient  = 0.739;
P = 0.008) when combining data from both vehicle and human
NPC groups, suggesting that reducing amyloid precursor protein
and improving axonal transport is important for recovery.
Effects of human neural precursor cells
on axonal transport are mediated by
vascular endothelial growth factor
The effect of human NPCs and human NPC-secreted factors on
axonal transport was determined in vitro using a microﬂuidic plat-
form with one chamber seeded with primary cortical neurons and
the other with or without human NPCs (Fig. 5D). Anterograde
transport of dextran-labelled vesicles in the axons of the cortical
neurons was measured in the axonal compartment (Fig. 5E). Co-
culture with human NPCs signiﬁcantly increased the mean velocity
of anterogradely transported vesicles (Fig. 5F and Supplementary
Fig. 5). Neutralization of VEGF, but not thrombospondins 1, 2,
SPARC or Slit, inhibited the human NPC-mediated effect
(Fig. 5F). Isotype control antibodies had no effect, and neutraliza-
tion of these factors had no effect in vehicle-treated wells.
Discussion
We show that human NPC transplantation at 1 week after stroke
signiﬁcantly improved functional recovery in several behaviour
tests and that this recovery correlated with human NPC-enhanced
changes in dendritic and axonal structural plasticity. Human NPCs
not only elicited these plasticity changes in the injured hemisphere
but also helped recruit the uninjured hemisphere. Moreover, we
demonstrate for the ﬁrst time that human NPC transplantation
enhanced recovery of stroke-impaired axonal transport. This is sig-
niﬁcant given the vital role of axonal transport for neuron func-
tion, survival and plasticity. Using co-culture assays, we could
mimic these human NPC-induced effects on plasticity and trans-
port in vitro, and through neutralization studies we identiﬁed four
secreted factors that mediate these human NPC-induced effects.
These data suggest that transplanted human NPCs enhance post-
stroke recovery by secretion of factors that enhance endogenous
brain repair mechanisms induced after stroke injury.
Figure 3 Human NPCs enhance axonal sprouting post-stroke. (A) Representative confocal images of biotinylated dextran amine (BDA)
staining in the contra- and ipsilateral corpus callosum of human NPC- and vehicle-treated animals at 5 weeks post-transplantation. Scale
bar = 100mm. (B) Human NPC-grafted rats have signiﬁcantly increased BDA-labelled ﬁbre density at 3 weeks (n = 6) and 5 weeks (n = 12)
post-transplantation in the cortex, corpus callosum and the ipsilesional striatum. At 5 weeks post-transplantation human NPC-grafted rats
also have increased BDA signal in (C) the ipsi- and contralesional thalamus and (D) corticospinal ﬁbres in the contralesional internal capsule
and both the contra- and ipsilesional dorsal funiculus in the cervical spinal cord, C5 level. *P50.05 human NPC compared with vehicle at
same time point. Red oval = BDA injection site; black oval = human NPC transplant site.
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the innate repair capacity of the brain
There is compelling evidence from both patient and animal data
that the brain undergoes reorganization and rewiring of surviving
circuits after ischaemia and this is postulated to underlie the spon-
taneous recovery observed after stroke (Dancause, 2006; Murphy
and Corbett, 2009; Benowitz and Carmichael, 2010). Such re-
storative neuronal plasticity changes include an increase in afferent
and efferent connections in both ipsi- and contralesional brain re-
gions, resulting in part from changes in dendritic and axonal
sprouting of surviving neurons.
Chronic changes in dendritic structural plasticity after stroke
have been reported with increased contralesional layer V dendritic
branching peaking at 18 days post-stroke (Jones and Schallert,
1992), while ipsilesional layer III branching was decreased (com-
pared with uninjured animals) at 9 weeks post-stroke (Gonzalez
and Kolb, 2003). Our data show for the ﬁrst time that at 3 weeks
post-stroke, human NPCs enhance dendritic length and arboriza-
tion in layer V cortical neurons in both the ipsi- and contralesional
cortex (despite the latter being remote from the site of transplant-
ation), and this coincided with the onset of human NPC-induced
functional recovery. Enhanced contralesional dendritic plasticity
after stroke is thought to be due to compensatory increased use
of the unimpaired limb (Jones and Schallert, 1994). However, this
is not apparent in the human NPC-treated animals; despite
enhanced contralesional plasticity they exhibit less relative use of
the unimpaired limb than vehicle controls. Thus, the signiﬁcance of
human NPC-enhanced contralesional dendritic plasticity and its
importance for early recovery remains to be determined. Of
note, vehicle injection was detrimental to dendritic plasticity at 2
weeks post-injection with recovery by 4 weeks. The human NPCs
appeared to prevent this injection injury, suggesting neuroprotec-
tive activity, be it direct or indirect. This raises the question
whether this neuroprotective effect is a signiﬁcant component of
human NPC-induced recovery in the ﬁrst few weeks following
transplantation.
Human NPC-induced dendritic changes in the contralesional
cortex were transient returning to baseline by 5 weeks post-stroke,
thus indicating that human NPCs could not prevent the contrale-
sional branch regression previously reported (Jones and Schallert,
Figure 4 Identiﬁcation of secreted factors mediating neurite
plasticity in vitro.( A) Representative images of cortical neurons
stained for microtubule-associated protein 2 (MAP2, labels
dendrites) and SMI312 (labels axons) co-cultured without
(vehicle) and with human NPCs. Scale = 50mm. (B–D) Human
NPCs signiﬁcantly promoted dendritic branching (B), total
dendritic length (C) and axonal outgrowth (D) of the cortical
neurons; *P50.05 ‘control human NPC’ compared with
‘control vehicle’. Neutralization of the secreted factors with
antibodies or the soluble slit receptor Roundabout-Fc
signiﬁcantly reduced the effects of human NPCs on these
parameters as indicated. *P50.05, **P50.01 compared
with ‘control human NPC’;
#P50.05 compared with ‘control
vehicle’. TSP = thrombospondins.
Table 1 Detection of human genes in human
NPC-transplanted rat tissue
Human gene Human NPCs Vehicle
Average
threshold
cycle
SD Average
threshold
cycle
SD
GAPDH 26.4 2.0 39.2 3.9
B2M 26.0 1.9 40.9 4.8
VEGFA 33.8 1.8 445 –
Thrombospondin 1 33.0 2.5 36.0 2.1
Thrombospondin 2 34.2 2.3 445 –
SPARC 28.7 3.1 445 –
SLIT1 36.7 1.9 39.0 1.4
SLIT2 40.1 1.9 43.7 0.9
SLIT3 33.7 1.4 35.0 1.2
Expression of human reference glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), b-2-microglobulin (B2M) and target genes was determined by quan-
titative polymerase chain reaction 7 days after human NPC or vehicle transplant-
ation into ischaemic animals (n = 4 per group). Genes were considered positive for
human-speciﬁc expression (indicated in bold) if the average threshold cycle was
535 in human NPC-transplanted tissue and 435 in vehicle-transplanted tissue.
Individual data points are displayed in Supplementary Fig. 3.
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for continued recovery at later time points. In contrast, ipsilesional
changes (i.e. in the human NPC-grafted hemisphere) were main-
tained at 1 month post-transplantation with no sign of abating,
suggesting that local effects of the human NPCs are necessary to
maintain dendritic changes. The biggest change in dendritic struc-
tural plasticity was observed in basilar dendrites where the major-
ity of synaptic inputs are found (Larkman, 1991); however, the
signiﬁcance of this for neuron function remains to be elucidated
(Nevian et al., 2007; Spruston, 2008). The pattern of early den-
dritic changes in the contralesional cortex followed by a switch to
more dominant changes in the ipsilesional cortex at later times is
reminiscent of brain remapping results in patients and animals.
These remapping studies show that stimulation of the injured
limb early after stroke recruits the contralesional cortex and this
switches back to the ipsilesional cortex at later time points
(Dancause, 2006; Benowitz and Carmichael, 2010). It would
thus be of interest to determine the signiﬁcance of these dendritic
changes to such remapping data.
Axonal sprouting occurs after stroke with new projections
thought to target areas denervated by the stroke injury
(Benowitz and Carmichael, 2010). In rodent and primate models
of ischaemic cortical injury, such sprouting has been observed
locally around the infarct area (Carmichael et al., 2001;
Conner et al., 2005; Dancause, 2006; Li et al., 2010), and
interhemispheric axonal outgrowth from the intact cortex to the
injured hemisphere has also been observed (Carmichael, 2008).
Our BDA axonal tracer data suggest that human NPC
transplantation promotes this interhemispheric cortical sprouting
in corticocortical, corticostriatal and corticothalamic pathways.
These data corroborate previous reports using human umbilical
cord blood cells (Xiao et al., 2005) and human embryonic-derived
neural progenitor cells (Daadi et al., 2010) in immunosuppressed
or immunocompetent animals, suggesting that this phenomenon is
independent of stem cell type used and T cell status of the host.
Consistent with enhanced axonal sprouting, human NPCs also
enhanced expression of the axonal growth cone protein GAP-43
in the same regions. However, GAP-43 is not purely a marker of
regenerating axons as it is also expressed on non-neuronal cells
such as astrocytes and oligodendrocytes (Carmichael, 2008); the
importance of this for regeneration is not understood.
Human NPC transplantation also enhanced stroke-induced
remodelling of cortical–spinal tract axons originating from the con-
tralesional cortex (i.e. intact corticospinal tract). The fact that the
number of BDA-labelled ﬁbres not only increased in the ipsilateral
dorsal funiculus (intact corticospinal tract) but also in the contra-
lateral dorsal funiculus (injured corticospinal tract) implies that
human NPCs may enhance collateral (cross midline) sprouting of
the intact corticospinal tract into denervated regions of the spinal
cord (Chen et al., 2002; Liu et al., 2008). Marrow stromal cell
treatment enhanced this collateral sprouting (Liu et al., 2008), but
unlike human NPC treatment, marrow stromal cells had no effect
on ﬁbre density in the intact corticospinal tract (Liu et al., 2008).
The human NPC-induced changes in both corticospinal tract and
transcallosal axonal sprouting statistically correlated with human
NPC-enhanced functional recovery; a similar correlation was
Figure 5 Effects of human NPCs on anterograde axonal transport in vivo and in vitro.( A) Representative confocal images of amyloid
precursor protein (APP) and SMI312 staining of the corpus callosum at 6 weeks post-stroke (5 weeks post-transplant) in uninjured (naı ¨ve),
vehicle treated (dMCAo, vehicle) and human NPC-grafted (dMCAo, hNPC) animals. Scale = 20mm( B) Quantiﬁcation of the percentage
of amyloid precursor protein-positive SMI312 puncta to determine the percentage of amyloid precursor protein-positive axons; 3 weeks,
n = 6; 5 weeks n = 12. (C) Quantiﬁcation of total axonal density at 6 weeks post-stroke (n = 12). (D) Schematic of microﬂuidic assay
system for analysis of axonal transport in vitro.( E) Time-lapse confocal images of dextran-labelled vesicles used to measure the rate of
axonal transport. Arrowhead indicates the same vesicle at different times. Scale = 5 mm. (F) Human NPCs enhance the rate of axonal
transport in cortical neurons compared with vehicle treatment. Neutralization of VEGF, but not other factors signiﬁcantly reduced this
human NPC-mediated effect. *P50.05, **P50.01. dMCAo = distal middle cerebral artery occlusion.
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cospinal tract sprouting (Liu et al., 2008, 2011). Together, these
data imply that human NPC-induced axonal plasticity is an import-
ant mechanism for human NPC-induced recovery, although a
direct causal link remains to be demonstrated.
A key ﬁnding of our study is the ability of human NPCs to en-
hance recovery of axonal transport after stroke. This has major
implications for recovery of white matter injury. Axonal transport
is disrupted after ischaemia (Kataoka et al., 1989; Valeriani et al.,
2000; Wakita et al., 2002) and is indicative of axonal damage.
Amyloid precursor protein is commonly used as a marker of im-
paired transport and axonal degeneration (Stone et al., 2000;
Valeriani et al., 2000) as it is constitutively expressed in neurons
and normally subject to fast axonal transport (Koo et al., 1990).
However, under pathological conditions, amyloid precursor protein
accumulates in axons, which can be both a consequence and a
cause of disrupted transport (Stone et al., 2000; Gunawardena
and Goldstein, 2001; Salehi et al., 2006). Our results conﬁrm
that stroke induces amyloid precursor protein accumulation in
the corpus callosum and it remains elevated at 6 weeks post-
stroke, implying extended perturbation of axonal transport.
Human NPC transplantation reduced amyloid precursor protein
accumulation and accelerated the decrease of amyloid precursor
protein over time, which strongly suggests that human NPCs en-
hance recovery of fast axonal transport after stroke. Furthermore,
by direct measurement of vesicle transport in cultured cortical
neurons, we conﬁrmed that human NPCs can enhance axonal
transport. This is a signiﬁcant ﬁnding as axonal transport is fun-
damental to neuron function, not only for proper functioning and
survival of existing axons but also for plasticity changes such as
axonal sprouting and synaptogenesis. Therefore, human NPC-
induced restoration of impaired axonal transport after stroke
may not only enhance the function of existing ﬁbre tracts
but may also be a key upstream event of human NPC-induced
structural plasticity.
Given that axonal tracers-like BDA undergo fast axonal trans-
port, this questions the interpretation of tract tracing data; is
increased axonal labelling really indicative of a greater number
of axons or does it merely reﬂect increased axonal transport?
Because axonal sprouting, transport and survival are somewhat
co-dependent, it probably represents a combination of events.
Consistent with this, human NPCs enhanced both axonal transport
and neurite outgrowth (measured directly) in vitro. Regardless of
mechanism, increased BDA labelling probably signiﬁes enhanced
ﬁbre tract integrity in vivo whether this is due to increased
numbers of axons or better functioning (transport) of axons. The
reduced atrophy of the corpus callosum observed in human
NPC-treated animals provides additional indirect evidence for
improved ﬁbre tract integrity.
Identiﬁcation of putative secreted
factors involved in human neural
precursor cell-mediated plasticity
The majority of the human NPCs remained in an immature state at
5 weeks post-stroke, therefore, differentiation into functionally
mature cells is not necessary for human NPC-induced recovery.
Instead, it is postulated that transplanted human NPCs elicit their
effects through secretion of relevant factors. Using in vitro
co-culture systems in which human NPCs mimicked the effects
observed in vivo, we identiﬁed secreted molecules putatively
involved in human NPC-induced axonal transport and neurite
sprouting. We found that thrombospondins 1 and 2, VEGF, Slit,
but not SPARC, were important for human NPC-induced dendritic
and axonal outgrowth. SPARC may require other cells (e.g. oligo-
dendrocytes) to potentiate its effects on neurite growth (Au et al.,
2007). Human NPCs also increased neuronal survival; whether this
is related to their effects on neurite outgrowth is unclear.
However, several mechanisms may be involved as depletion of
thrombospondin 2 and Slit only affected neurite outgrowth with-
out affecting cell survival. Only VEGF was important for human
NPC-enhanced axonal transport. VEGF has previously been re-
ported to be transported by axons (Storkebaum et al., 2005),
whether this is important for its effects on axonal transport re-
mains to be determined.
Because most antibodies used in these experiments may bind
both human and rodent forms of the protein, further studies are
required to determine whether direct secretion of these factors by
the human NPCs or human NPC-induced secretion of these fac-
tors by the primary rat cultures is important for the observed ef-
fects. However, neutralization of VEGF was achieved using
Avastin, which binds human but not rodent VEGF (Ferrara
et al., 2004), strongly implying that direct secretion of VEGF by
human NPCs plays a signiﬁcant role. Furthermore, using a small
interfering RNA knockdown approach, Yu et al. (2008) reported
that thrombospondin 1 was important for marrow stromal
cell-induced neurite outgrowth in retinal ganglion cell cultures,
thus strengthening the idea that direct secretion of thrombospon-
din by human NPCs is involved.
Whether these factors are also important for the in vivo effects
of human NPCs remains to be determined but at least many of
them are expressed by the human NPCs in the stroke brain. We
have previously reported the importance of stem cell-secreted
VEGF for human NPC-induced functional recovery (Horie et al.,
2011). Thrombospondins 1 and 2 are also strong candidates since
growing evidence suggests the importance of thrombospondins
after stroke as they are upregulated after cerebral ischaemia
(Lin et al., 2003), and we recently reported that thrombospondins
1 and 2 knockout mice have reduced functional recovery and
axonal sprouting after stroke (Liauw et al., 2008). Thus, these
human NPC-secreted factors warrant further investigation,
but clearly other modulatory factors will also be involved
(Carmichael, 2008).
Translational implications
Human NPCs have clinical potential for stroke therapy and we
(Svendsen) have a clinical grade bank of foetal-derived human
NPCs, which makes this a realistic goal. Understanding the
mode of action of human NPCs in the post-ischaemic brain will
be important for the successful translation of cell transplantation
strategies to the clinic. For example, if modulation of host brain
plasticity is a major human NPC mechanism of action, this could
1786 | Brain 2011: 134; 1777–1789 R. H. Andres et al.dictate the best time to transplant cells after stroke; ‘network re-
learning’ occurs within weeks of stroke and continues for several
months, making it a good therapeutic target with a large time
window of intervention. Furthermore, knowing what changes
the human NPCs elicit in the brain offers useful surrogate indica-
tors of transplanted cell activity. For example, changes in ﬁbre
tract integrity can be monitored non-invasively with diffusion
tensor MRI, which can evaluate cell therapy efﬁcacy and also
highlight potential side effects resulting from too much or inappro-
priate human NPC-induced plasticity. Moving from the bench to
the clinic also raises cell manufacturing issues, in particular design-
ing bioassays to predict clinical efﬁcacy of the cell product. Our
data imply that human NPC-induced changes in neurite sprouting
and axonal transport would be useful predictors of cell efﬁcacy.
Therefore, the in vitro assays we developed here to test these
parameters, with their potential for high throughput, could serve
as useful bioassays. Finally, the translational feasibility of human
NPC therapy will depend on many variables including the differ-
ence in scale between the rodent and human brain which may
affect the ability of human NPCs to induce effective plasticity.
Furthermore, patients experience a rehabilitative or enriched
post-stroke environment compared to laboratory animals, which
per se is reported to enhance plasticity and recovery in rodents
(Biernaskie and Corbett, 2001; Wurm et al., 2007). Therefore,
demonstrating that human NPCs can further enhance recovery
in rats under enriched conditions will be critical (Mattsson et al.,
1997; Hicks et al., 2007). These issues warrant further investiga-
tion as cell therapies move to the clinics.
Conclusion
In summary, we have demonstrated that transplanted human
NPCs enhance axonal transport, dendritic branching and axonal
sprouting of host neurons after stroke, and that these plasticity
changes correlated with human NPC-induced recovery.
Furthermore, we identiﬁed several secreted factors that mediated
these same changes in vitro. Therefore, we postulate that trans-
planted human NPCs aid in recovery through secretion of factors
that enhance the natural brain remapping that occurs following
stroke. Such a mechanism of action offers a large therapeutic
window for post-stroke stem cell intervention.
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